Article ID Journal Published Year Pages File Type
8445182 European Journal of Cancer 2013 11 Pages PDF
Abstract
Northwestern University, Onyx Pharmaceuticals, Bayer Healthcare Pharmaceuticals.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer
Authors
, , , , , , , , , ,